{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:33:19Z","timestamp":1790854399228,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\u03b8-Defensins are cyclic octadecapeptides found in nonhuman primates whose broad antiviral spectrum includes HIV-1, HSV-1, severe acute respiratory syndrome coronavirus, and influenza A virus (IAV). We previously reported that synthetic \u03b8-defensins called retrocyclins can neutralize and aggregate various strains of IAV and increase IAV uptake by neutrophils. This study describes two families of peptides, hapivirins and diprovirins, whose design was inspired by retrocyclins. The goal was to develop smaller partially cyclic peptides that retain the antiviral activity of retrocyclins, while being easier to synthesize. The novel peptides also allowed for systemic substitution of key residues to evaluate the role of charge or hydrophobicity on antiviral activity. Seventy-two hapivirin or diprovirin peptides are described in this work, including several whose anti-IAV activity equals or exceeds that of normal \u03b1- or \u03b8-defensins. Some of these also had strong antibacterial and antifungal activity. These new peptides were active against H3N2 and H1N1 strains of IAV. Structural features imparting strong antiviral activity were identified through iterative cycles of synthesis and testing. Our findings show the importance of hydrophobic residues for antiviral activity and show that pegylation, which often increases a peptide\u2019s serum t1\/2 in vivo, can increase the antiviral activity of DpVs. The new peptides acted at an early phase of viral infection, and, when combined with pulmonary surfactant protein D, their antiviral effects were additive. The peptides strongly increased neutrophil and macrophage uptake of IAV, while inhibiting monocyte cytokine generation. Development of modified \u03b8-defensin analogs provides an approach for creating novel antiviral agents for IAV infections.<\/jats:p>","DOI":"10.4049\/jimmunol.1101335","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T05:40:48Z","timestamp":1329370848000},"page":"2759-2768","source":"Crossref","is-referenced-by-count":34,"title":["Hapivirins and Diprovirins: Novel \u03b8-Defensin Analogs with Potent Activity against Influenza A Virus"],"prefix":"10.1093","volume":"188","author":[{"given":"Mona","family":"Doss","sequence":"first","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ruchala","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California , Los Angeles, Los Angeles, CA 90095"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfaldet","family":"Tecle","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Gantz","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hartshorn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika C","family":"Crouch","sequence":"additional","affiliation":[{"name":"Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, MO 63110"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Luong","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California , Los Angeles, Los Angeles, CA 90095"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa D","family":"Micewicz","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California , Los Angeles, Los Angeles, CA 90095"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert I","family":"Lehrer","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California , Los Angeles, Los Angeles, CA 90095"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevan L","family":"Hartshorn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,15]]},"reference":[{"key":"2025032409590276800_r1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jama.289.2.227","article-title":"Influenza-related mortality: considerations for practice and public health","volume":"289","author":"Morens","year":"2003","journal-title":"JAMA"},{"key":"2025032409590276800_r2","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/507546","article-title":"Lessons learned from reconstructing the 1918 influenza pandemic","volume":"194","author":"Garcia-Sastre","year":"2006","journal-title":"J. Infect. Dis."},{"key":"2025032409590276800_r3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/1744666X.4.4.497","article-title":"Innate immunity to influenza virus: implications for future therapy","volume":"4","author":"White","year":"2008","journal-title":"Expert Rev. Clin. Immunol."},{"key":"2025032409590276800_r4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1753425910365734","article-title":"Review: defensins and cathelicidins in lung immunity","volume":"16","author":"Tecle","year":"2010","journal-title":"Innate Immun."},{"key":"2025032409590276800_r5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/521027","article-title":"alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s)","volume":"196","author":"Salvatore","year":"2007","journal-title":"J. Infect. Dis."},{"key":"2025032409590276800_r6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ni1248","article-title":"Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins","volume":"6","author":"Leikina","year":"2005","journal-title":"Nat. Immunol."},{"key":"2025032409590276800_r7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1128\/jvi.60.3.1068-1074.1986","article-title":"Direct inactivation of viruses by human granulocyte defensins","volume":"60","author":"Daher","year":"1986","journal-title":"J. Virol."},{"key":"2025032409590276800_r8","doi-asserted-by":"crossref","first-page":"e25333","DOI":"10.1371\/journal.pone.0025333","article-title":"Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37","volume":"6","author":"Barlow","year":"2011","journal-title":"PLoS One"},{"key":"2025032409590276800_r9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1189\/jlb.0609382","article-title":"Human defensins and LL-37 in mucosal immunity","volume":"87","author":"Doss","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"2025032409590276800_r10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrmicro976","article-title":"Primate defensins","volume":"2","author":"Lehrer","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"2025032409590276800_r11","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2174\/1381612033454667","article-title":"Minidefensins: antimicrobial peptides with activity against HIV-1","volume":"9","author":"Cole","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"2025032409590276800_r12","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1073\/pnas.052706399","article-title":"Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1","volume":"99","author":"Cole","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032409590276800_r13","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.peptides.2003.07.023","article-title":"Evolution of primate theta-defensins: a serpentine path to a sweet tooth","volume":"24","author":"Nguyen","year":"2003","journal-title":"Peptides"},{"key":"2025032409590276800_r14","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1371\/journal.pbio.1000095","article-title":"Reawakening retrocyclins: ancestral human defensins active against HIV-1","volume":"7","author":"Venkataraman","year":"2009","journal-title":"PLoS Biol."},{"key":"2025032409590276800_r15","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.4049\/jimmunol.0804049","article-title":"Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D","volume":"182","author":"Doss","year":"2009","journal-title":"J. Immunol."},{"key":"2025032409590276800_r16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI117323","article-title":"Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses","volume":"94","author":"Hartshorn","year":"1994","journal-title":"J. Clin. Invest."},{"key":"2025032409590276800_r17","doi-asserted-by":"crossref","first-page":"L1293","DOI":"10.1152\/ajplung.00266.2007","article-title":"Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid","volume":"293","author":"White","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2025032409590276800_r18","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.4049\/jimmunol.176.11.6962","article-title":"Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D","volume":"176","author":"Hartshorn","year":"2006","journal-title":"J. Immunol."},{"key":"2025032409590276800_r19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4049\/jimmunol.141.4.1295","article-title":"Effects of influenza A virus on human neutrophil calcium metabolism","volume":"141","author":"Hartshorn","year":"1988","journal-title":"J. Immunol."},{"key":"2025032409590276800_r20","first-page":"L958","article-title":"Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria","volume":"274","author":"Hartshorn","year":"1998","journal-title":"Am. J. Physiol."},{"key":"2025032409590276800_r21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3011.1990.tb00939.x","article-title":"Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids","volume":"35","author":"Fields","year":"1990","journal-title":"Int. J. Pept. Protein Res."},{"key":"2025032409590276800_r22","first-page":"L753","article-title":"Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A","volume":"271","author":"Hartshorn","year":"1996","journal-title":"Am. J. Physiol."},{"key":"2025032409590276800_r23","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.4049\/jimmunol.165.4.2108","article-title":"Enhanced antiviral and opsonic activity of a human mannose-binding lectin and surfactant protein D chimera","volume":"165","author":"White","year":"2000","journal-title":"J. Immunol."},{"key":"2025032409590276800_r24","first-page":"L1156","article-title":"Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins","volume":"273","author":"Hartshorn","year":"1997","journal-title":"Am. J. Physiol."},{"key":"2025032409590276800_r25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/ar700259k","article-title":"Beta-hairpin peptidomimetics: design, structures and biological activities","volume":"41","author":"Robinson","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"2025032409590276800_r26","article-title":"Influenza-associated bacterial pathogens in patients with 2009 influenza A (H1N1) infection: impact of community-associated methicillin resistant Staphylococcus aureus (MRSA) in Queensland, Australia","author":"Hayashi","year":"2011","journal-title":"Intern. Med. J."},{"key":"2025032409590276800_r27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.annemergmed.2008.04.027","article-title":"Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season","volume":"53","author":"Kallen","year":"2009","journal-title":"Ann. Emerg. Med."},{"key":"2025032409590276800_r28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1172\/JCI103791","article-title":"Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza","volume":"38","author":"Louria","year":"1959","journal-title":"J. Clin. Invest."},{"key":"2025032409590276800_r29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.1995.1313","article-title":"Assessment of fusogenic properties of influenza virus hemagglutinin deacylated by site-directed mutagenesis and hydroxylamine treatment","volume":"210","author":"Philipp","year":"1995","journal-title":"Virology"},{"key":"2025032409590276800_r30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-5793(86)80662-7","article-title":"Membrane fusion induced by influenza virus hemagglutinin requires protein bound fatty acids","volume":"202","author":"Lambrecht","year":"1986","journal-title":"FEBS Lett."},{"key":"2025032409590276800_r31","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1021\/bi700720e","article-title":"Retrocyclin-2: structural analysis of a potent anti-HIV theta-defensin","volume":"46","author":"Daly","year":"2007","journal-title":"Biochemistry"},{"key":"2025032409590276800_r32","doi-asserted-by":"crossref","first-page":"7936","DOI":"10.4049\/jimmunol.181.11.7936","article-title":"Multimerization of surfactant protein D, but not its collagen domain, is required for antiviral and opsonic activities related to influenza virus","volume":"181","author":"White","year":"2008","journal-title":"J. Immunol."},{"key":"2025032409590276800_r33","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.4049\/jimmunol.180.4.2562","article-title":"CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality","volume":"180","author":"Lin","year":"2008","journal-title":"J. Immunol."},{"key":"2025032409590276800_r34","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1128\/JVI.02336-06","article-title":"Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice","volume":"81","author":"Szretter","year":"2007","journal-title":"J. Virol."},{"key":"2025032409590276800_r35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10529-009-0167-2","article-title":"Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro","volume":"32","author":"Liang","year":"2010","journal-title":"Biotechnol. Lett."},{"key":"2025032409590276800_r36","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1128\/JVI.01363-09","article-title":"Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease","volume":"83","author":"Wohlford-Lenane","year":"2009","journal-title":"J. Virol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/188\/6\/2759\/61631532\/1101335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/188\/6\/2759\/61631532\/1101335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T18:24:54Z","timestamp":1743099894000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/188\/6\/2759\/7981311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,3,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1101335","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,3]]},"published":{"date-parts":[[2012,3]]}}}